Augmentation Therapy Reduces Frequency of Lung Infections in Antitrypsin Deficiency
- 1 November 2000
- Vol. 118 (5) , 1480-1485
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Randomized Clinical Trial of α1-Antitrypsin Augmentation TherapyAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Survival and FEV1 Decline in Individuals with Severe Deficiency of α1-AntitrypsinAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEuropean Respiratory Journal, 1997
- A Role for Intermediate, Heterozygous Alpha1-Antitrypsin Deficiency in Obstructive Lung DiseaseChest, 1990
- Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiencyThe American Journal of Medicine, 1988
- Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with EmphysemaNew England Journal of Medicine, 1987
- Alpha1-Antitrypsin Pi-Types in 965 COPD PatientsChest, 1986
- Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.Journal of Clinical Investigation, 1981
- α1-Antitrypsin is an effector of immunological stasisNature, 1978
- Heterozygous and Homozygous Alpha1-Antitrypsin Deficiency in Patients with Pulmonary EmphysemaNew England Journal of Medicine, 1969